Marc A. Began
Vice President and General Counsel
Mr. Marc Began joined Abiomed in June 2018 and serves as vice president, general counsel, and secretary responsible for leading the company’s legal and compliance functions worldwide. Mr. Began has worked as a lawyer for more than 20 years, supporting various sectors of the life sciences industry, including pharmaceuticals, medical devices, and biotechnology. He joined Abiomed from Boehringer Ingelheim where he was vice president of intellectual property responsible for medical device, pharmaceutical, and biologic intellectual property issues.
Before joining Boehringer Ingelheim, Mr. Began held various positions of increasing responsibility at Novo Nordisk during a 15-year period. As assistant general counsel, he oversaw complex litigation matters. He also supported strategic transactions and business development. Prior to that, as assistant chief IP counsel, he managed global patent portfolios and enforcement strategy. Before joining Novo Nordisk, Mr. Began was an associate at the law firms of Sullivan & Cromwell and White & Case in New York where he handled a broad range of legal matters, including litigation, intellectual property, corporate transactions, regulatory and compliance.
Mr. Began earned a Juris Doctor degree from Albany Law School at Union University and holds a Bachelor of Science degree in mechanical engineering from Rensselaer Polytechnic Institute. He is also a licensed professional engineer and previously practiced engineering with the New York State Department of Environmental Conservation.